|
POLG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
6.34419999867575E-08 |
| Normal-vs-Stage3 |
5.7666982300475E-11 |
| Normal-vs-Stage4 |
6.12780000075475E-08 |
| Stage1-vs-Stage2 |
5.544600E-01 |
| Stage1-vs-Stage3 |
2.862300E-03 |
| Stage1-vs-Stage4 |
8.689900E-02 |
| Stage2-vs-Stage3 |
1.313210E-01 |
| Stage2-vs-Stage4 |
4.736600E-01 |
| Stage3-vs-Stage4 |
5.057200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.89929960647817E-10 |
| Normal-vs-Asian |
5.414100E-04 |
| Caucasian-vs-AfricanAmerican |
7.595200E-03 |
| Caucasian-vs-Asian |
1.115700E-02 |
| AfricanAmerican-vs-Asian |
3.338400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.433600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.403200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.552800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.339600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.965200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.195400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.803600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.485200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.962200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.59610000000288E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
4.12679999994836E-06 |
| Grade 1-vs-Grade 2 |
3.217000E-04 |
| Grade 1-vs-Grade 3 |
2.039900E-04 |
| Grade 1-vs-Grade 4 |
3.4510000002097E-07 |
| Grade 2-vs-Grade 3 |
3.685000E-01 |
| Grade 2-vs-Grade 4 |
1.179160E-03 |
| Grade 3-vs-Grade 4 |
1.456110E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.37709962824795E-10 |
| ccA subtype-vs-ccB subtype |
1.53859999996175E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.116360E-02 |
| N0-vs-N1 |
5.981200E-01 |
|
|
